-
公开(公告)号:US20200165356A1
公开(公告)日:2020-05-28
申请号:US16375777
申请日:2019-04-04
Applicant: Xencor, Inc.
Inventor: John Desjarlais , Alex Nisthal , Seung Chu
Abstract: The present invention relates to novel antigen binding domains and heterodimeric antibodies that bind Fibroblast Activation Protein (FAP).
-
公开(公告)号:US10519242B2
公开(公告)日:2019-12-31
申请号:US14214475
申请日:2014-03-14
Applicant: Xencor, Inc.
Inventor: Seung Chu , Matthew Bernett , Dilki Wickramarachchi , John Desjarlais
Abstract: The present invention provides methods and compositions comprising a heterodimeric antibody comprising a first monomer comprising a first variant heavy chain constant region and an anti-CD4 binding moiety. The heterodimeric antibody also comprises a second monomer comprising: a second variant heavy chain constant region and an anti-CD25 binding moiety. In some cases, the pIs of the first and second variant heavy chain constant regions are at least 0.5 logs apart.
-
公开(公告)号:US20190352416A1
公开(公告)日:2019-11-21
申请号:US16530946
申请日:2019-08-02
Applicant: Xencor, Inc.
Inventor: Gregory Moore , John Desjarlais , Seung Chu , Sung-Hyung Lee
IPC: C07K16/28
Abstract: Provided herein are trispecific antibodies that include a) a first monomer, b) a second monomer, and c) a light chain. The first monomer includes a first variant Fc domain and a variable heavy domain, the second monomer includes a second variant Fc domain and a first scFv domain and the light chain includes a variable light domain. The variable heavy domain and the variable light domain form an antigen binding domain. The trispecific antibody further includes a second scFv domain on either the first or second monomers.
-
公开(公告)号:US20190202938A1
公开(公告)日:2019-07-04
申请号:US16354058
申请日:2019-03-14
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
CPC classification number: C07K16/468 , A61K2039/505 , C07K16/2809 , C07K16/2866 , C07K16/2887 , C07K16/2896 , C07K16/30 , C07K16/3061 , C07K16/40 , C07K2317/24 , C07K2317/31 , C07K2317/35 , C07K2317/515 , C07K2317/52 , C07K2317/522 , C07K2317/526 , C07K2317/528 , C07K2317/55 , C07K2317/565 , C07K2317/60 , C07K2317/622 , C07K2317/64 , C07K2317/70 , C07K2317/73 , C07K2317/92 , C07K2317/94
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:US20190194325A1
公开(公告)日:2019-06-27
申请号:US16297255
申请日:2019-03-08
Applicant: Xencor, Inc.
Inventor: Matthew Bernett , Seung Chu , Dilki Wickramarachichi , John Desjarlais
IPC: C07K16/28
CPC classification number: C07K16/2812 , A61K2039/505 , C07K16/2818 , C07K16/2866 , C07K2317/30 , C07K2317/31 , C07K2317/52 , C07K2317/56 , C07K2317/565 , C07K2317/622
Abstract: The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
-
公开(公告)号:US20180223000A1
公开(公告)日:2018-08-09
申请号:US15945681
申请日:2018-04-04
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
CPC classification number: C07K16/468 , A61K2039/505 , C07K16/2809 , C07K16/2866 , C07K16/2887 , C07K16/2896 , C07K16/30 , C07K16/3061 , C07K16/40 , C07K2317/24 , C07K2317/31 , C07K2317/35 , C07K2317/515 , C07K2317/52 , C07K2317/522 , C07K2317/526 , C07K2317/528 , C07K2317/55 , C07K2317/565 , C07K2317/60 , C07K2317/622 , C07K2317/64 , C07K2317/70 , C07K2317/73 , C07K2317/92 , C07K2317/94
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
公开(公告)号:US20170320947A1
公开(公告)日:2017-11-09
申请号:US15372360
申请日:2016-12-07
Applicant: Xencor, Inc.
Inventor: Gregory Moore , John Desjarlais , Seung Chu
CPC classification number: C07K16/2809 , A61K38/02 , C07K2/00 , C07K16/1027 , C07K16/3069 , C07K2317/24 , C07K2317/31 , C07K2317/55 , C07K2317/622 , C07K2317/74 , C07K2317/90 , C07K2317/92
Abstract: The present invention is directed to heterodimeric antibodies that bind CD3 and PSMA.
-
公开(公告)号:US20170081420A1
公开(公告)日:2017-03-23
申请号:US15185958
申请日:2016-06-17
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal , Sung-Hyung Lee
CPC classification number: C07K16/468 , A61K2039/505 , C07K16/2809 , C07K16/2818 , C07K16/2896 , C07K16/30 , C07K16/3061 , C07K2317/24 , C07K2317/31 , C07K2317/35 , C07K2317/515 , C07K2317/52 , C07K2317/522 , C07K2317/526 , C07K2317/528 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/60 , C07K2317/622 , C07K2317/64 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
Abstract: The present invention is directed to novel heterodimeric antibodies.
-
49.
公开(公告)号:US20160229924A1
公开(公告)日:2016-08-11
申请号:US14952714
申请日:2015-11-25
Applicant: Xencor, Inc.
Inventor: Matthew J. Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal
CPC classification number: C07K16/468 , A61K2039/505 , C07K16/2809 , C07K16/2818 , C07K16/2896 , C07K16/30 , C07K16/3061 , C07K2317/24 , C07K2317/31 , C07K2317/35 , C07K2317/515 , C07K2317/52 , C07K2317/522 , C07K2317/526 , C07K2317/528 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/60 , C07K2317/622 , C07K2317/64 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2317/94
Abstract: The present invention is directed to novel heterodimeric antibodies.
Abstract translation: 本发明涉及新型异二聚体抗体。
-
50.
公开(公告)号:US20140294836A1
公开(公告)日:2014-10-02
申请号:US14214475
申请日:2014-03-14
Applicant: Xencor, Inc.
Inventor: Seung Chu , Matthew Bernett , Dilki Wickramarachchi
IPC: C07K16/28
CPC classification number: C07K16/2866 , C07K16/2812 , C07K2317/31 , C07K2317/71 , C07K2317/72 , C07K2317/732
Abstract: The present invention provides methods and compositions comprising a heterodimeric antibody comprising a first monomer comprising a first variant heavy chain constant region and an anti-CD4 binding moiety. The heterodimeric antibody also comprises a second monomer comprising: a second variant heavy chain constant region and an anti-CD25 binding moiety. In some cases, the pIs of the first and second variant heavy chain constant regions are at least 0.5 logs apart.
Abstract translation: 本发明提供包含异二聚体抗体的方法和组合物,所述异二聚体抗体包含包含第一变体重链恒定区和抗CD4结合部分的第一单体。 异二聚体抗体还包含第二单体,其包含:第二变体重链恒定区和抗CD25结合部分。 在一些情况下,第一和第二变体重链恒定区的pI至少为0.5log。
-
-
-
-
-
-
-
-
-